Inflammatory Bowel Disease
Conditions
Interventions
II.Intervened group: Patients who are randomly assigned to receive total colonoscopy with PCF-PQ260. Intervention is at the day when patients are examined by total colonoscopy.
II.Control group: Patie
Sponsors
Hyogo College of Medicine, Dept. of Internal medicine, Lower gastroenterology
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: I.IBD patients undergoing an elective, diagnostic, or screening colonoscopy at Hyogo college of Medicine Hospital are prospectively included. II.Patients who had a diagnosis of IBD before colonoscopy III.Patient was able to provide written informed consent to total colonoscopy basically without sedation and being randomized to the new ultrathin flexible scope (PCF-PQ260) group or to the conventional scope (PCF-Q260A) group. IV.Patients aged 18 or older.
Exclusion criteria
Exclusion criteria: I.Cases of the short bowel syndrome. II.Cases that have obvious bleeding from intestine and possibility of perforation. III.Cases of the megacolon or toxic megacolon. IV.Cases that have severe stenosis or adhesion. V.Cases that have severe inflammation and high risk for colonoscopy. VI.Patients could not provide consent or when patients preferred to receive sedation/analgesia from the start. VII.Patient had undergone prior partial colonic resection VIII.Cases whose preparation was incomplete before colonoscopy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| I. Patients rating of procedural pain related to colonoscopy by visual analogue scale | — |
Secondary
| Measure | Time frame |
|---|---|
| II. The facilitation of intubation II-1. Completeness of intubation to the cecum II-2. Time required for intubation to the cecum III. Procedural complications in colonoscopy | — |
Countries
Japan
Contacts
Public ContactYoshio Ohda MD.Ph.D.
Hyogo College of Medicine Dept.of Internal medicine, Lower gastroenterology
Outcome results
None listed